| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Endocrinology (I.V.P., J.M.K.) and Unit for Osteoporosis and Metabolic Bone Diseases (I.V.P., S.G., J.M.K.), Ghent University Hospital, 9000 Ghent, Belgium
Address all correspondence and requests for reprints to: Prof. J. M. Kaufman, Department of Endocrinology (9K12IE), Ghent University Hospital, De Pintelaan 185, Ghent, Belgium. E-mail: Jean.Kaufman{at}rug.ac.be.
The question of whether and to what extent the sex steroid deficiency in elderly men contributes to the pathogenesis of bone loss has not been fully explored. The aim of the present study was to assess the association of serum bioavailable (Bio) estradiol (E2) with the evolution of bone mineral density (BMD) in 214 community-dwelling men aged 71–86 yr as well as the possible modulation of estrogen effects by a tetranucleotide (TTTA)n-repeat polymorphism of the CYP19 gene, which encodes the aromatase enzyme that converts androgens into estrogens. BMD was measured at yearly intervals over a period of 4 yr using dual x-ray absorptiometry. Fasting blood was analyzed at baseline for testosterone (T), E2, and SHBG; the respective bioavailable fractions, BioT and BioE2, were calculated. Serum BioE2 was associated with baseline BMD at different assessed skeletal sites, with correlation coefficients ranging between 0.23 and 0.37 (P < 0.001). Estimated annual percentage change of BMD (%BMD) was -0.39% [95% confidence index (CI), -0.56, -0.22] at the total hip, -0.04% (95% CI, -0.29, 0.21) at the femoral neck, and -0.37% (95% CI, -0.45, -0.29) at the total distal forearm. Higher circulating BioE2 levels were associated with less bone loss at the forearm and the hip (P < 0.05). The CYP19 gene (TTTA)n-repeat length (determined by fragment analysis) was not associated with baseline BMD in the total group of elderly men. However, a significant association was observed between the CYP19 genotype and BMD change at the distal forearm; the highest bone loss was observed in subjects homozygotic for the shortest observed allele length of (TTTA)7-repeats (P < 0.02). The CYP19 (TTTA)n-repeat length was not associated with either baseline BioE2 or the BioT/BioE2 ratio. In multiple linear regression models, the CYP19 genotype and serum BioE2 were determinants of %BMD change at the forearm (P < 0.05). No significant contribution of BioT to %BMD change was evident. As to fracture risk, the allele containing the shortest (TTTA)n-repeat length was more represented not only in elderly men with a positive personal fracture history (Pearson’s 
2 test = 4.03; df = 1; P = 0.05) but also in study subjects with a positive fracture history in their first-degree relatives (Pearson’s 2 test = 6.48; df = 1; P = 0.01). In conclusion, the results of this prospective observational study support the view that BioE2 is a determinant of bone density changes in elderly men and, furthermore, provide an indication that the aromatase enzyme may exert a direct modulatory action on bone metabolism at the tissue level in elderly men.
This work was supported by the Fund for Scientific Research (FWO Vlaanderen Grant G0058-97). I.V.P. is a research fellow for the Fund for Scientific Research (FWO Vlaanderen). Part of this work was presented at the International Osteoporosis Foundation World Congress on Osteoporosis, Lisbon, Portugal, May 2002.
I.V.P. and S.G. contributed equally to this manuscript.
Abbreviations: Bio, Bioavailable; BMD, bone mineral density; %BMD, percentage BMD; Cr, creatinine; CV, coefficient(s) of variation; E2, estradiol; S-CTX, serum C-terminal telopeptides of type I collagen; T, testosterone; U-CTX, urinary C-terminal telopeptides of type I collagen; U-DPD, urinary deoxypyridinoline; X/X, noncarriers of the (TTTA)7-allele; 7/X, heterozygotic carriers of the (TTTA)7-allele; 7/7, homozygotic carriers of the (TTTA)7-allele.
This article has been cited by other articles:
 |
|
 |
|
  C. Ohlsson and L. Vandenput The role of estrogens for male bone health Eur. J. Endocrinol., June 1, 2009; 160(6): 883 - 889. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. G. Travison, A. B. Araujo, T. J. Beck, R. E. Williams, R. V. Clark, B. Z. Leder, and J. B. McKinlay Relation between Serum Testosterone, Serum Estradiol, Sex Hormone-Binding Globulin, and Geometrical Measures of Adult Male Proximal Femur Strength J. Clin. Endocrinol. Metab., March 1, 2009; 94(3): 853 - 860. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B Lapauw, S Goemaere, H Zmierczak, I Van Pottelbergh, A Mahmoud, Y Taes, D De Bacquer, S Vansteelandt, and J M Kaufman The decline of serum testosterone levels in community-dwelling men over 70 years of age: descriptive data and predictors of longitudinal changes Eur. J. Endocrinol., October 1, 2008; 159(4): 459 - 468. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Khosla, S. Amin, and E. Orwoll Osteoporosis in Men Endocr. Rev., June 1, 2008; 29(4): 441 - 464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. Araujo, T. G. Travison, B. Z. Leder, and J. B. McKinlay Correlations between Serum Testosterone, Estradiol, and Sex Hormone-Binding Globulin and Bone Mineral Density in a Diverse Sample of Men J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2135 - 2141. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Czajka-Oraniec, W. Zgliczynski, A. Kurylowicz, M. Mikula, and J. Ostrowski Association between gynecomastia and aromatase (CYP19) polymorphisms Eur. J. Endocrinol., May 1, 2008; 158(5): 721 - 727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bjornerem, L. A. Ahmed, R. M. Joakimsen, G. K R. Berntsen, V. Fonnebo, L. Jorgensen, P. Oian, E. Seeman, and B. Straume A prospective study of sex steroids, sex hormone-binding globulin, and non-vertebral fractures in women and men: the Tromso Study Eur. J. Endocrinol., July 1, 2007; 157(1): 119 - 125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Lin, O. Ercan, J. Raza, C. P. Burren, S. M. Creighton, R. J. Auchus, M. T. Dattani, and J. C. Achermann Variable Phenotypes Associated with Aromatase (CYP19) Insufficiency in Humans J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 982 - 990. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T Zarrabeitia, J. L Hernandez, C. Valero, A. Zarrabeitia, J. A Amado, J. Gonzalez-Macias, and J. A Riancho Adiposity, estradiol, and genetic variants of steroid-metabolizing enzymes as determinants of bone mineral density Eur. J. Endocrinol., January 1, 2007; 156(1): 117 - 122. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ferrari Single Gene Mutations and Variations Affecting Bone Turnover and Strength: a Selective 2006 Update IBMS BoneKEy, December 1, 2006; 3(12): 11 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. A. Fink, S. K. Ewing, K. E. Ensrud, E. Barrett-Connor, B. C. Taylor, J. A. Cauley, E. S. Orwoll, and for the Osteoporotic Fractures in Men Study Group Association of Testosterone and Estradiol Deficiency with Osteoporosis and Rapid Bone Loss in Older Men J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3908 - 3915. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Crabbe, S. Goemaere, H. Zmierczak, I. Van Pottelbergh, D. De Bacquer, and J.-M. Kaufman Are serum leptin and the Gln223Arg polymorphism of the leptin receptor determinants of bone homeostasis in elderly men? Eur. J. Endocrinol., May 1, 2006; 154(5): 707 - 714. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Bilezikian What's Good for the Goose's Skeleton is Good for the Gander's Skeleton. J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1223 - 1225. [Full Text] [PDF]
|
|
|
|
|
|
V Rochira, A Balestrieri, B Madeo, L Zirilli, A R M Granata, and C Carani Osteoporosis and male age-related hypogonadism: role of sex steroids on bone (patho)physiology Eur. J. Endocrinol., February 1, 2006; 154(2): 175 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. X. Ma, A. A. Adjei, O. E. Salavaggione, J. Coronel, L. Pelleymounter, L. Wang, B. W. Eckloff, D. Schaid, E. D. Wieben, A. A. Adjei, et al. Human Aromatase: Gene Resequencing and Functional Genomics Cancer Res., December 1, 2005; 65(23): 11071 - 11082. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Kaufman and A. Vermeulen The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications Endocr. Rev., October 1, 2005; 26(6): 833 - 876. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C E Schuit, F. H de Jong, L. Stolk, W N. H Koek, J. B J van Meurs, M. W C J Schoofs, M C. Zillikens, A. Hofman, J. P T M van Leeuwen, H. A P Pols, et al. Estrogen receptor alpha gene polymorphisms are associated with estradiol levels in postmenopausal women Eur. J. Endocrinol., August 1, 2005; 153(2): 327 - 334. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Gennari, R. Nuti, and J. P. Bilezikian Aromatase Activity and Bone Homeostasis in Men J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 5898 - 5907. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Van Pottelbergh, S. Goemaere, H. Zmierczak, and J. M. Kaufman Perturbed Sex Steroid Status in Men with Idiopathic Osteoporosis and Their Sons J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4949 - 4953. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Gennari, L. Masi, D. Merlotti, L. Picariello, A. Falchetti, A. Tanini, C. Mavilia, F. Del Monte, S. Gonnelli, B. Lucani, et al. A Polymorphic CYP19 TTTA Repeat Influences Aromatase Activity and Estrogen Levels in Elderly Men: Effects on Bone Metabolism J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2803 - 2810. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Khosla, B. L. Riggs, E. J. Atkinson, A. L. Oberg, C. Mavilia, F. Del Monte, L. J. Melton III, and M. L. Brandi Relationship of Estrogen Receptor Genotypes to Bone Mineral Density and to Rates of Bone Loss in Men J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1808 - 1816. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
